Tuesday, October 27, 2026
MARKETS & IPO
NIFTY 50 24466.8500 INR ▲ +0.85% | BSE SENSEX 80365.2000 INR ▲ +0.72% | NASDAQ 100 18518.6000 USD ▲ +1.15% | S&P 500 5808.1200 USD ▲ +0.64% | DOW JONES 42387.5000 USD ▼ -0.33% | NIKKEI 225 38981.7500 JPY ▲ +1.82% | GOLD (10g) 78550.0000 INR ▲ +0.42% | SILVER (1kg) 97200.0000 INR ▲ +1.28% | CRUDE OIL 74.8500 USD ▼ -1.60% | BITCOIN 67920.0000 USD ▲ +2.84% | ETHEREUM 2530.4000 USD ▲ +1.95% | USD / INR 84.0800 INR ▲ +0.05% | IPO Hyundai Motor India IPO ₹1,865-₹1,960 (GMP +₹65) | IPO Swiggy Limited IPO ₹371-₹390 (GMP +₹25) | IPO NTPC Green Energy IPO ₹102-₹108 (GMP +₹12) | IPO Waaree Energies IPO ₹1,427-₹1,503 (GMP +₹1,325) | IPO Reddit Inc. IPO $34.00 (Current $64.20) | IPO Rubrik Inc. IPO $32.00 (Current $38.50) | IPO Vishal Mega Mart IPO ₹74-₹78 (Est. GMP +₹14) | IPO HDB Financial Services IPO ₹700-₹740 (Est. GMP +₹120) | IPO Afcons Infrastructure IPO ₹440-₹463 (GMP +₹15) | IPO Sagility India IPO ₹28-₹30 (GMP +₹3) | IPO ACME Solar Holdings IPO ₹275-₹289 (GMP +₹18) | IPO Niva Bupa Health Insurance IPO ₹70-₹74 (GMP +₹4) | NIFTY 50 24466.8500 INR ▲ +0.85% | BSE SENSEX 80365.2000 INR ▲ +0.72% | NASDAQ 100 18518.6000 USD ▲ +1.15% | S&P 500 5808.1200 USD ▲ +0.64% | DOW JONES 42387.5000 USD ▼ -0.33% | NIKKEI 225 38981.7500 JPY ▲ +1.82% | GOLD (10g) 78550.0000 INR ▲ +0.42% | SILVER (1kg) 97200.0000 INR ▲ +1.28% | CRUDE OIL 74.8500 USD ▼ -1.60% | BITCOIN 67920.0000 USD ▲ +2.84% | ETHEREUM 2530.4000 USD ▲ +1.95% | USD / INR 84.0800 INR ▲ +0.05% | IPO Hyundai Motor India IPO ₹1,865-₹1,960 (GMP +₹65) | IPO Swiggy Limited IPO ₹371-₹390 (GMP +₹25) | IPO NTPC Green Energy IPO ₹102-₹108 (GMP +₹12) | IPO Waaree Energies IPO ₹1,427-₹1,503 (GMP +₹1,325) | IPO Reddit Inc. IPO $34.00 (Current $64.20) | IPO Rubrik Inc. IPO $32.00 (Current $38.50) | IPO Vishal Mega Mart IPO ₹74-₹78 (Est. GMP +₹14) | IPO HDB Financial Services IPO ₹700-₹740 (Est. GMP +₹120) | IPO Afcons Infrastructure IPO ₹440-₹463 (GMP +₹15) | IPO Sagility India IPO ₹28-₹30 (GMP +₹3) | IPO ACME Solar Holdings IPO ₹275-₹289 (GMP +₹18) | IPO Niva Bupa Health Insurance IPO ₹70-₹74 (GMP +₹4) |
CUBIQNEWS By Cubiq Infotech
Science & Space Exploration

Common drugs may help dangerous viruses spread through the body

S
Editorial Staff
Oct 27, 2026 at 12:00 AM
2 min read 1 views
AI Audio Reader
Listen to this article
Click play to listen
Common drugs may help dangerous viruses spread through the body
AI Story Highlights (Quick Read)

A surprising discovery reveals that widely used anti-inflammatory drugs may unintentionally help dangerous viruses spread through the body. Scientists found that JAK inhibitors, prescribed fo

⚡ Key Highlights

A surprising discovery reveals that widely used anti-inflammatory drugs may unintentionally help dangerous viruses spread through the body. Scientists found that JAK inhibitors, prescribed fo

Medications are designed to treat diseases and relieve symptoms, but some can also produce unintended effects that put patients at risk. While side effects are common with many treatments, researchers have identified a particularly concerning possibility involving drugs used to control inflammation.

Scientists at the Norwegian University of Science and Technology (NTNU) have discovered that a widely used class of anti-inflammatory medications may make it easier for certain viruses to infect cells and spread throughout the body.

"We have found a surprising and potentially serious side effect of a class of anti-inflammatory drugs. They can help viruses spread more easily in the body," says Denis Kainov, a professor at the Department of Clinical and Molecular Medicine at the Norwegian University of Science and Technology (NTNU).

The medications at the center of the findings belong to a class called Janus kinase inhibitors, or JAKs. These drugs are widely prescribed to control inflammation, but their effects on the immune system may also leave the body more vulnerable to viral infections.

"Among the viruses that more easily affect the body with the help of these drugs are Rift Valley fever virus, influenza A, adenovirus and SARS-CoV-2, the virus that causes COVID-19," Kainov says.

These viruses can cause significant illness, making any treatment that potentially increases their ability to spread a serious concern.

In a new study published in NAR Molecular Medicine, Kainov and his colleagues investigated how JAK inhibitors influence the body's ability to defend itself against viruses.

"JAK inhibitors are often prescribed for autoimmune diseases and inflammatory conditions such as rheumatoid arthritis," says Erlend Ravlo, a PhD research fellow at NTNU and first author of the article.

Fair Use & Copyright Disclosure Request Removal

This article is an automated digital summary compiled from authentic journalistic wire reports for informational and educational purposes in accordance with 17 U.S.C. § 107 (Fair Use Doctrine). All intellectual property, quotes, trademarks, and original journalism belong exclusively to their original copyright holders. Cubiq Infotech claims no proprietary ownership over third-party news media.

DMCA Policy • Editorial Transparency • Publisher: Cubiq Infotech
What is your reaction? Click an emotion to vote
Share this story

Community Comments (0)

No comments yet. Download our mobile app to join the live community conversation!

Get Cubiq News App

Audio News & Instant Alerts

Install Free